106 related articles for article (PubMed ID: 9923846)
1. aHIF: the missing link between HIF-1 and VHL?
Neckers LM
J Natl Cancer Inst; 1999 Jan; 91(2):106-7. PubMed ID: 9923846
[No Abstract] [Full Text] [Related]
2. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.
Barry RE; Krek W
Trends Mol Med; 2004 Sep; 10(9):466-72. PubMed ID: 15350900
[No Abstract] [Full Text] [Related]
3. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
4. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
[TBL] [Abstract][Full Text] [Related]
5. Overview: integrating renal hypoxic signals in development and disease.
Daniel TO
J Am Soc Nephrol; 2003 Nov; 14(11):2693-4. PubMed ID: 14569077
[No Abstract] [Full Text] [Related]
6. Much huffing about HIF: oxygen dependent proline hydroxylation and the regulation of hypoxia inducible factors.
Robinson B
Pediatr Res; 2001 Dec; 50(6):673. PubMed ID: 11726718
[No Abstract] [Full Text] [Related]
7. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.
Mandriota SJ; Turner KJ; Davies DR; Murray PG; Morgan NV; Sowter HM; Wykoff CC; Maher ER; Harris AL; Ratcliffe PJ; Maxwell PH
Cancer Cell; 2002 Jun; 1(5):459-68. PubMed ID: 12124175
[TBL] [Abstract][Full Text] [Related]
8. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
Maynard MA; Ohh M
Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
Tanimoto K; Makino Y; Pereira T; Poellinger L
EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
[TBL] [Abstract][Full Text] [Related]
10. HIF hydroxylation and the mammalian oxygen-sensing pathway.
Safran M; Kaelin WG
J Clin Invest; 2003 Mar; 111(6):779-83. PubMed ID: 12639980
[No Abstract] [Full Text] [Related]
11. Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes.
Biju MP; Neumann AK; Bensinger SJ; Johnson RS; Turka LA; Haase VH
Mol Cell Biol; 2004 Oct; 24(20):9038-47. PubMed ID: 15456877
[TBL] [Abstract][Full Text] [Related]
12. Oxygen sensing in cancer.
Pugh CW
Ann Med; 2003; 35(6):380-90. PubMed ID: 14572161
[TBL] [Abstract][Full Text] [Related]
13. The von Hippel-Lindau tumor suppressor gene.
Kondo K; Kaelin WG
Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of the von Hippel-Lindau-like protein.
Qi H; Gervais ML; Li W; DeCaprio JA; Challis JR; Ohh M
Mol Cancer Res; 2004 Jan; 2(1):43-52. PubMed ID: 14757845
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones.
Tsuchiya MI; Okuda H; Takaki Y; Baba M; Hirai S; Ohno S; Shuin T
Oncol Rep; 2005 Jun; 13(6):1033-41. PubMed ID: 15870918
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
Rankin EB; Higgins DF; Walisser JA; Johnson RS; Bradfield CA; Haase VH
Mol Cell Biol; 2005 Apr; 25(8):3163-72. PubMed ID: 15798202
[TBL] [Abstract][Full Text] [Related]
17. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.
Baba M; Hirai S; Yamada-Okabe H; Hamada K; Tabuchi H; Kobayashi K; Kondo K; Yoshida M; Yamashita A; Kishida T; Nakaigawa N; Nagashima Y; Kubota Y; Yao M; Ohno S
Oncogene; 2003 May; 22(18):2728-38. PubMed ID: 12743597
[TBL] [Abstract][Full Text] [Related]
18. Cancer. Many vessels, faulty gene.
Kaelin WG
Nature; 1999 May; 399(6733):203-4. PubMed ID: 10353237
[No Abstract] [Full Text] [Related]
19. Insights into the role of the von Hippel-Lindau gene product. A key player in hypoxic regulation.
Maxwell PH; Pugh CW; Ratcliffe PJ
Exp Nephrol; 2001; 9(4):235-40. PubMed ID: 11423722
[TBL] [Abstract][Full Text] [Related]
20. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
Yu F; White SB; Zhao Q; Lee FS
Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
